Revisão Acesso aberto Revisado por pares

Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life

2004; Elsevier BV; Volume: 44; Issue: 6 Linguagem: Inglês

10.1051/rnd

ISSN

1297-9708

Autores

Jean‐Marc Alessandri, Philippe Guesnet, Sylvie Vancassel, Pierre Astorg, Isabelle Denis, Bénédicte Langelier, Saba Aïd, Carine Poumès‐Ballihaut, Gaëlle Champeil‐Potokar, Monique Lavialle,

Tópico(s)

Eicosanoids and Hypertension Pharmacology

Resumo

Docosahexaenoic acid (DHA, 22:6n-3) and arachidonic acid (AA, 20:4n-6) are the major polyunsaturated fatty acids in the membranes of brain and retinal cells.Animals specifically deficient in dietary n-3 fatty acids have low DHA content in their membranes, reduced visual acuity and impaired learning ability.Studies on bottle-fed human infants have shown that adding DHA and AA to milk replacer-formulas can bring their concentrations in the infant blood lipids to values as high as those produced by breast-feeding and significantly improves mental development and maturation of visual function.In older subjects, diverse neuropsychiatric and neurodegenerative diseases have been associated to decreased blood levels of n-3 PUFA.Low intakes of fish or of n-3 PUFA in populations have been associated with increased risks of depression and Alzheimer disease, and n-3 PUFA, especially eicosapentaenoic acid (EPA, 20:5n-3), have shown efficacy as adjunctive treatment -and in some cases as the only treatment -in several psychiatric disorders.The mechanisms by which polyunsaturated fatty acids have an impact on neuronal functions will be reviewed: the modulation of membrane biophysical properties, regulation of neurotransmitter release, synthesis of biologically active oxygenated derivatives, and nuclear receptor-mediated transcription of genes responsive to fatty acids or to their derivatives.docosahexaenoic acid / arachidonic acid / retina / brain / milk feeding / eicosanoids / synaptic terminals / phototransduction / neuroprotection / nuclear receptors / neuropsychiatric diseases / neurodegenerative diseases

Referência(s)